Agamree有几种规格?多少钱?

Agamree (vamorolone) is a new glucocorticoid drug for the treatment of Duchenne muscular dystrophy (DMD). Its specifications and price information are crucial to patients' medication decisions. This article will introduce in detail the current specifications, market price system and key precautions in clinical use of this drug, providing a practical reference for medical professionals and patients.

Agamree is available in several specifications

Standardized formulation protocols are currently used globally, and specifications are designed to meet clinical needs.

Single dosage form design

Agamree only provides one dosage form, oral suspension, with a concentration of 40mg/mL. This unified design simplifies the dosage calculation and medication management process.

Standard packaging specifications

The medicines are in fixed packaging, and each box contains one bottle of 120mL suspension. This packaging capacity can meet the monthly treatment needs of most patients while ensuring drug stability.

Uniform specification design reduces the risk of medication errors and facilitates inventory management by medical institutions.

How much does Agamree cost in different specifications?

As an innovative drug for the treatment of rare diseases, Agamree’s pricing strategy reflects its research and development value and clinical benefits.

Basic pricing

The official price of Swiss Santhera is US$9,764 per box (120mL), which includes drug research and development investment and continuous safety monitoring costs.

Regional price adjustment

Some European countries have obtained 8%-12% price discounts through medical insurance negotiations. Prices in the U.S. market remain stable, but distribution channels may add a 3%-5% service fee.

Cost Support Program

Pharmaceutical companies have established tiered assistance plans to provide 30%-70% cost reductions based on patients’ financial status. Some commercial insurance plans can cover 50%-80% of drug costs.

Understanding the price system can help patient families evaluate the cost of treatment and choose the most appropriate payment plan.

Notes on Agamree

Rational use of Agamree requires attention to the potential impacts of multiple systems. A standardized monitoring program is the basis for safe medication use.

Endocrine management

Regularly assess signs of Cushing's syndrome and monitor fasting blood glucose and adrenal function. Abrupt discontinuation of the drug may result in adrenal crisis and requires gradual tapering.

Infection Prevention and Control

Avoid contact with patients with infectious diseases during treatment. People with latent tuberculosis infection need to complete 9 months of isoniazid preventive treatment, and timely injection of immune globulin is required after exposure to chickenpox.

System monitoring requirements

Monthly measurement of blood pressure and electrolytes, especially in elderly patients. Long-term treatment patients should undergo bone density testing every 6 months, and supplement calcium and vitamin D if necessary.

Management of special groups

Patients with a history of gastrointestinal surgery should use it with caution. If depressive symptoms occur, timely intervention is required and consideration should be given to reducing the dose or switching to an alternative solution.

Standard medication monitoring can maximize the efficacy and reduce the risk of adverse reactions.